company background image
JBCHEPHARM logo

J. B. Chemicals & Pharmaceuticals NSEI:JBCHEPHARM Stock Report

Last Price

₹1.65k

Market Cap

₹256.0b

7D

1.9%

1Y

68.9%

Updated

28 Mar, 2024

Data

Company Financials +

J. B. Chemicals & Pharmaceuticals Limited

NSEI:JBCHEPHARM Stock Report

Market Cap: ₹256.0b

JBCHEPHARM Stock Overview

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.

JBCHEPHARM fundamental analysis
Snowflake Score
Valuation1/6
Future Growth5/6
Past Performance5/6
Financial Health5/6
Dividends4/6

J. B. Chemicals & Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for J. B. Chemicals & Pharmaceuticals
Historical stock prices
Current Share Price₹1,650.40
52 Week High₹1,940.00
52 Week Low₹875.00
Beta-0.052
1 Month Change0.40%
3 Month Change1.59%
1 Year Change68.86%
3 Year Change163.62%
5 Year Change847.82%
Change since IPO2,085.24%

Recent News & Updates

Recent updates

J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 09
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models

J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

Dec 22
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar

We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

Nov 29
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt

J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

Aug 03
J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Feb 11
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50

Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

Dec 03
Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?

A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Sep 21
A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Aug 03
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly

Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Jun 15
Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

Mar 29
Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

Feb 16
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50

With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting

Jan 27
With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting

J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt

Nov 30
J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt

Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today

Sep 24
Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today

Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?

Aug 03
Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?

Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?

Jun 14
Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?

How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?

May 04
How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?

Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?

Mar 13
Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?

This Insider Has Just Sold Shares In J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

Feb 28
This Insider Has Just Sold Shares In J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)

What Kind Of Shareholders Hold The Majority In J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Shares?

Feb 26
What Kind Of Shareholders Hold The Majority In J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Shares?

Interested In J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Upcoming ₹8.50 Dividend? You Have Three Days Left

Feb 13
Interested In J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Upcoming ₹8.50 Dividend? You Have Three Days Left

Shareholder Returns

JBCHEPHARMIN PharmaceuticalsIN Market
7D1.9%2.7%2.5%
1Y68.9%63.9%47.3%

Return vs Industry: JBCHEPHARM exceeded the Indian Pharmaceuticals industry which returned 63.9% over the past year.

Return vs Market: JBCHEPHARM exceeded the Indian Market which returned 47.3% over the past year.

Price Volatility

Is JBCHEPHARM's price volatile compared to industry and market?
JBCHEPHARM volatility
JBCHEPHARM Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.6%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.0%

Stable Share Price: JBCHEPHARM has not had significant price volatility in the past 3 months.

Volatility Over Time: JBCHEPHARM's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19765,095Nikhil Choprahttps://www.jbpharma.com

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company’s API product portfolio includes diclofenac sodium, dimethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms.

J. B. Chemicals & Pharmaceuticals Limited Fundamentals Summary

How do J. B. Chemicals & Pharmaceuticals's earnings and revenue compare to its market cap?
JBCHEPHARM fundamental statistics
Market cap₹255.99b
Earnings (TTM)₹5.14b
Revenue (TTM)₹33.85b

49.8x

P/E Ratio

7.6x

P/S Ratio

Is JBCHEPHARM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
JBCHEPHARM income statement (TTM)
Revenue₹33.85b
Cost of Revenue₹11.85b
Gross Profit₹22.00b
Other Expenses₹16.86b
Earnings₹5.14b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)33.13
Gross Margin65.00%
Net Profit Margin15.19%
Debt/Equity Ratio16.6%

How did JBCHEPHARM perform over the long term?

See historical performance and comparison

Dividends

0.7%

Current Dividend Yield

31%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.